NO980103L - Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerest - Google Patents
Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerestInfo
- Publication number
- NO980103L NO980103L NO980103A NO980103A NO980103L NO 980103 L NO980103 L NO 980103L NO 980103 A NO980103 A NO 980103A NO 980103 A NO980103 A NO 980103A NO 980103 L NO980103 L NO 980103L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- acid residue
- peptide
- growth hormone
- pharmaceutical composition
- Prior art date
Links
- 125000000539 amino acid group Chemical group 0.000 title abstract 4
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 230000002378 acidificating effect Effects 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000006240 deamidation Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88195P | 1995-07-12 | 1995-07-12 | |
| PCT/DK1996/000290 WO1997002833A1 (en) | 1995-07-12 | 1996-06-28 | A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980103L true NO980103L (no) | 1998-01-09 |
| NO980103D0 NO980103D0 (no) | 1998-01-09 |
Family
ID=21693419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO980103A NO980103D0 (no) | 1995-07-12 | 1998-01-09 | Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerest |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0837690A1 (cs) |
| JP (1) | JPH11510483A (cs) |
| KR (1) | KR19990028908A (cs) |
| CN (1) | CN1190896A (cs) |
| AU (1) | AU699850B2 (cs) |
| BR (1) | BR9609573A (cs) |
| CA (1) | CA2226553A1 (cs) |
| CZ (1) | CZ6198A3 (cs) |
| HU (1) | HUP9802286A3 (cs) |
| IL (1) | IL122519A0 (cs) |
| NO (1) | NO980103D0 (cs) |
| PL (1) | PL324386A1 (cs) |
| WO (1) | WO1997002833A1 (cs) |
| ZA (1) | ZA965367B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100236393B1 (ko) * | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | 사람성장호르몬을 함유하는 의약제제 |
| US6566329B1 (en) | 1999-06-28 | 2003-05-20 | Novo Nordisk A/S | Freeze-dried preparation of human growth hormone |
| WO2002011695A2 (en) | 2000-08-07 | 2002-02-14 | Inhale Therapeutic Systems, Inc. | Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| TW200501987A (en) * | 2002-12-11 | 2005-01-16 | Santen Pharmaceutical Co Ltd | Ophthalmic solution preservatives |
| CN103751769B (zh) * | 2013-12-25 | 2015-08-19 | 楼秀余 | 一种冻干重组人生长激素胶囊及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816568A (en) * | 1986-05-16 | 1989-03-28 | International Minerals & Chemical Corp. | Stabilization of growth hormones |
| ATE368472T1 (de) * | 1991-12-20 | 2007-08-15 | Novo Nordisk As | Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält |
| DK204791D0 (da) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | Hidtil ukendt farmaceutisk praeparat |
| JPH10511964A (ja) * | 1995-01-13 | 1998-11-17 | ノボ ノルディスク アクティーゼルスカブ | 成長ホルモン及びＸ−Ｌｙｓを含む安定化医薬製剤 |
-
1996
- 1996-06-25 ZA ZA965367A patent/ZA965367B/xx unknown
- 1996-06-28 IL IL12251996A patent/IL122519A0/xx unknown
- 1996-06-28 AU AU63533/96A patent/AU699850B2/en not_active Ceased
- 1996-06-28 HU HU9802286A patent/HUP9802286A3/hu unknown
- 1996-06-28 CA CA002226553A patent/CA2226553A1/en not_active Abandoned
- 1996-06-28 EP EP96922774A patent/EP0837690A1/en not_active Withdrawn
- 1996-06-28 BR BR9609573A patent/BR9609573A/pt not_active Application Discontinuation
- 1996-06-28 KR KR1019980700210A patent/KR19990028908A/ko not_active Ceased
- 1996-06-28 CN CN96195465A patent/CN1190896A/zh active Pending
- 1996-06-28 PL PL96324386A patent/PL324386A1/xx unknown
- 1996-06-28 JP JP9505422A patent/JPH11510483A/ja active Pending
- 1996-06-28 WO PCT/DK1996/000290 patent/WO1997002833A1/en not_active Ceased
- 1996-06-28 CZ CZ9861A patent/CZ6198A3/cs unknown
-
1998
- 1998-01-09 NO NO980103A patent/NO980103D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0837690A1 (en) | 1998-04-29 |
| JPH11510483A (ja) | 1999-09-14 |
| HUP9802286A3 (en) | 1999-06-28 |
| AU6353396A (en) | 1997-02-10 |
| CA2226553A1 (en) | 1997-01-30 |
| KR19990028908A (ko) | 1999-04-15 |
| PL324386A1 (en) | 1998-05-25 |
| ZA965367B (en) | 1997-01-23 |
| IL122519A0 (en) | 1998-06-15 |
| CN1190896A (zh) | 1998-08-19 |
| HUP9802286A2 (hu) | 1999-02-01 |
| BR9609573A (pt) | 1999-03-02 |
| CZ6198A3 (cs) | 1998-06-17 |
| MX9800309A (es) | 1998-07-31 |
| AU699850B2 (en) | 1998-12-17 |
| NO980103D0 (no) | 1998-01-09 |
| WO1997002833A1 (en) | 1997-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942299L (no) | Stabilisert, farmasöytisk preparat som omfatter veksthormon og asparagin | |
| NO980155L (no) | Stabilisert farmasöytisk preparat som omfatter et veksthormon som er forbehandlet med sink og eventuelt lysin eller kasiumioner | |
| CA2102693A1 (en) | Protein formulation comprising growth hormone | |
| PT785795E (pt) | Composicao farmaceutica | |
| EP1197222A3 (en) | A stabilized pharmaceutical formulation comprising growth hormone and histidine | |
| ZA958604B (en) | A pharmaceutical formulation | |
| ATE326233T1 (de) | Langfristig stabilisierte g-csf präparate | |
| WO1995025749A3 (en) | Eating suppressant peptides | |
| DK1014948T3 (da) | Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider | |
| NO980103L (no) | Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerest | |
| NO991995L (no) | Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav | |
| AR076950A2 (es) | Analogos del peptido 1-similar al glucagon uso de los mismos para la manufactura de un medicamento y composiciones farmaceuticas que los contienen | |
| ES2172594T3 (es) | Una formulacion farmaceutica que comprende una hormona de crecimiento y leucina. | |
| ES2150421T3 (es) | Nuevos conjugados, consistentes en una glicoproteina y una sustancia que se fija a acidos nucleicos. | |
| NO942323L (no) | Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering | |
| WO1989001490A3 (en) | Biologically active molecules | |
| GB1119353A (en) | Peptides having an adrenocorticotropic hormone action and process for their manufacture | |
| AU2900989A (en) | Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |